Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Carmustine 7.7mg implant |
| BNF code | 0801010D0AAABAB |
| Virtual Therapeutic Moiety | Carmustine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 5 Jan 2005 |
| Previous name | Carmustine 7.7mg implants |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products Available |
| Non-availability status date | 23 Jan 2024 |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | device |
| Unit dose unit of measure | device |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Carmustine |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 7.700 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | implant.intralesional |
| Dose Form | |
| Formulation | Prolonged-release intralesional implant |
| Drug Route | |
| Route | Intralesional |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Gliadel 7.7mg implant (Clinigen Healthcare Ltd) | |
| Virtual Medicinal Product Packs | |
| Carmustine 7.7mg implant 8 device | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.